| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
15,280,000 |
| Market
Cap: |
102.22(M) |
| Last
Volume: |
1,505,916 |
Avg
Vol: |
1,501,805 |
| 52
Week Range: |
$2.25 - $8.09 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8.6 |
| Insider 6 Months : 11.3 |
| Insider 3/6 Months : 20.1 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Delcath Systems is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Co.'s primary product candidate, the HEPZATO™ KIT (melphalan hydrochloride for injection/hepatic delivery system) (HEPZATO), is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In Europe, Co.'s commercial product is a stand-alone medical device having the same device components as the HEZPATO but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT® Hepatic Delivery System for Melphalan.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
53,764 |
127,764 |
382,819 |
547,434 |
| Total Buy Value |
$200,002 |
$419,962 |
$1,081,809 |
$1,686,989 |
| Total People Bought |
2 |
4 |
8 |
9 |
| Total Buy Transactions |
2 |
4 |
10 |
15 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Brege Laura |
Director |
– • – |
2014-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
9,616 |
11,678 |
|
- |
|
| Leung Gabriel |
Director |
– • – |
2014-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
14,424 |
21,485 |
|
- |
|
| Konidaris Tasos |
Director |
– • – |
2014-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
9,616 |
11,678 |
|
- |
|
| Leung Gabriel |
Director |
– • – |
2013-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,500 |
98,027 |
|
- |
|
| Appling William M |
EVP, R&D and Global Operations |
• – – |
2013-06-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,450 |
|
- |
|
| Leung Gabriel |
Director |
– • – |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
81,527 |
|
- |
|
| Stoll Roger G Phd |
Director |
– • – |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
117,534 |
|
- |
|
| Brege Laura |
Director |
– • – |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
33,000 |
|
- |
|
| Konidaris Tasos |
Director |
– • – |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
33,000 |
|
- |
|
| Watson Douglas G |
Director |
– • – |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
127,049 |
|
- |
|
| Philips Laura A |
Director |
– • – |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
196,534 |
|
- |
|
| Koplewicz Harold S |
Director |
– • – |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
49,500 |
247,041 |
|
- |
|
| Watson Douglas G |
Director |
– • – |
2012-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
32,680 |
94,049 |
|
- |
|
| Stoll Roger G Phd |
Director |
– • – |
2012-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
32,680 |
84,534 |
|
- |
|
| Philips Laura A |
Director |
– • – |
2012-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
32,680 |
163,534 |
|
- |
|
| Leung Gabriel |
Director |
– • – |
2012-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
32,680 |
48,527 |
|
- |
|
| Koplewicz Harold S |
Director |
– • – |
2012-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
49,020 |
197,541 |
|
- |
|
| Leung Gabriel |
Director |
– • – |
2012-06-15 |
4 |
B |
$1.57 |
$11,762 |
D/D |
7,500 |
15,847 |
2.39 |
- |
|
| Philips Laura A |
Director |
– • – |
2012-06-01 |
4 |
B |
$1.43 |
$98,050 |
D/D |
65,000 |
130,854 |
2.39 |
- |
|
| Watson Douglas G |
Director |
– • – |
2012-06-01 |
4 |
B |
$1.51 |
$75,275 |
D/D |
50,000 |
61,369 |
2.39 |
- |
|
| Purpura John |
EVP Reg. Affairs/Quality Assur |
• – – |
2012-06-01 |
4 |
B |
$1.49 |
$7,450 |
D/D |
5,000 |
20,000 |
2.74 |
- |
|
| Hobbs Eamonn P |
President and CEO |
• • – |
2012-06-01 |
4 |
B |
$1.52 |
$10,611 |
D/D |
7,000 |
162,000 |
2.81 |
- |
|
| Simpson Jennifer K. |
Exec. VP, Global Marketing |
• – – |
2012-06-01 |
4 |
B |
$1.49 |
$4,470 |
D/D |
3,000 |
10,750 |
2.66 |
- |
|
| Simpson Jennifer K. |
Exec. VP, Global MarketingOffi |
• – – |
2012-03-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250 |
|
- |
|
| Simpson Jennifer K. |
Exec. VP, Global Marketing |
• – – |
2012-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,750 |
|
- |
|
370 Records found
|
|
Page 6 of 15 |
|
|
0.17 (2.48%) 
